NTRA - Natera - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

NTRA is currently covered by 17 analysts with an average price target of $186.85. This is a potential upside of $28.67 (18.12%) from yesterday's end of day stock price of $158.18.

Natera's activity chart (see below) currently has 211 price targets and 199 ratings on display. The stock rating distribution of NTRA is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 87.12% with an average time for these price targets to be met of 325.58 days.

Highest price target for NTRA is $210, Lowest price target is $125, average price target is $164.31.

Most recent stock forecast was given by DAVID WESTENBERG from PIPER SANDLER on 15-May-2025. First documented stock forecast 27-Jul-2015.

Currently out of the existing stock ratings of NTRA, 65 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$210

$49.57 (30.90%)

$205

1 months 29 days ago
(15-May-2025)

14/17 (82.35%)

$60.6 (40.56%)

378

Buy

$185

$24.57 (15.32%)

$176

4 months 9 days ago
(05-Mar-2025)

10/11 (90.91%)

$37.08 (25.07%)

177

Buy

$195

$34.57 (21.55%)

$180

4 months 16 days ago
(28-Feb-2025)

10/13 (76.92%)

$39.41 (25.33%)

505

Buy

$190

$29.57 (18.43%)

$140

5 months 16 days ago
(28-Jan-2025)

9/10 (90%)

$21.92 (13.04%)

130

Buy

$210

$49.57 (30.90%)

$157

6 months 1 days ago
(13-Jan-2025)

1/2 (50%)

$40.7 (24.04%)

1

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is NTRA (Natera) average time for price targets to be met?

On average it took 325.58 days on average for the stock forecasts to be realized with a an average price target met ratio 87.12

Which analyst has the current highest performing score on NTRA (Natera) with a proven track record?

MAX MASUCCI

Which analyst has the most public recommendations on NTRA (Natera)?

Max Masucci has 2 price targets and 3 ratings on NTRA

Which analyst is the currently most bullish on NTRA (Natera)?

Sandy Draper with highest potential upside - $91.42

Which analyst is the currently most reserved on NTRA (Natera)?

Steve Beuchaw with lowest potential downside - -$135.43

Natera in the News

Natera Presents Data at ESMO GI on its Tissue-Free Latitudeā„¢ MRD* Assay, Demonstrating Excellent Overall Performance in Colorectal Cancer

AUSTIN, Texas, July 07, 2025–(BUSINESS WIRE)–Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced data from a colorectal cancer (CRC) study of its tissue-free Latitudeā„¢ MRD assay, which were presented at the 2025 European Society for Medical Oncology GI Congress (ESMO GI). The clinical performance of the assay was...

Q1 2025 Natera Inc Earnings Call

Participants Michael Brophy; Chief Financial Officer; Natera Inc Steven Chapman; Chief Executive Officer, Director; Natera Inc Solomon Moshkevich; President – Clinical Diagnostics; Natera Inc Alexey Aleshin; General Manager of Oncology and Early Cancer Detection (ECD) & Chief Medical Officer; Natera Inc Dan Brennan; Analyst; TD Cowen Tejas Savant; Analyst; Morgan Stanley Rachel Vatnsdal; Analyst; JPMorgan...
Show more

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?